Microscopic mechanisms of fibrosis
A healthy organ synthesizes normal extracellular matrix elements, including types I, III, and IV collagens, fibronectin, and laminin. Exposure to damaging factors distorts this process, leading to structural remodeling of the sinusoids.
Excessive connective tissue deposition localizes in the perisinusoidal space (space of Disse). This results in a dense collagen framework, leading to the phenomenon of "sinusoidal capillarization". Normally permeable hepatic sinusoids transform into conventional capillaries with a dense basement membrane.
This creates a mechanical barrier to adequate metabolic exchange between the blood flowing in the sinusoids and hepatocytes. Cellular hypoxia develops, closing a vicious circle: it causes further damage and accelerates the progression of fibrosis up to cirrhosis.
Key mediators and cellular activators
The essence of fibrogenesis is a severe imbalance between the synthesis of extracellular matrix structural components and their degradation. The primary participants in this cascade are hepatic stellate cells (Ito cells).
Under the influence of triggers (viral agents, alcohol, autoimmune reactions, metabolic disorders, or cholestasis), the density of cytokine receptors on the surface of Ito cells increases sharply. The proliferation process is stimulated by a wide range of biologically active substances:
- Reactive oxygen species (ROS).
- Growth factors: insulin-like (IGF-1), fibroblast (FGF), transforming (TGF-β1).
- Pro-inflammatory cytokines: tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1).
- Other mediators: endothelin-1, nitric oxide (NO), interferon-gamma (IFN-γ).
Cascade of liver pathology development
The development of liver pathology proceeds as a sequential algorithm leading to irreversible changes:
- Exposure to an etiological factor. This may include viral infections, mechanical barriers (cholestasis), toxins (drugs, alcohol), autoantibodies, or malnutrition.
- Cellular damage. The hepatocyte is always the target. The exposure leads either to cell death via necrosis or apoptosis, or to severe metabolic disruption (fatty degeneration).
- Structural remodeling. In response to cell death, the void spaces are actively filled with connective tissue—hepatic fibrosis is initiated.
- Terminal stage. Uncontrolled progression of fibrosis culminates in the development of liver cirrhosis (LC) or a malignant neoplasm (hepatocellular carcinoma).
Main clinical and laboratory syndromes
The basis of differential diagnosis relies on identifying specific biochemical syndromes, each with its own markers:
- Cytolytic syndrome: reflects the destruction (necrosis) of hepatocytes. Intracellular enzymes—transaminases (ALT, AST), LDH, and GLDH—are massively released into the bloodstream.
- Mesenchymal-inflammatory syndrome: activation of the immune system and mesenchymal-stromal elements of the liver. Acute-phase indicators (ESR, CRP), immunoglobulins, and the γ-globulin fraction increase.
- Cholestatic syndrome: impaired bile formation or outflow. Manifests as an elevation in direct bilirubin, as well as the enzymes ALP and GGT.
- Hepatic cell insufficiency: suppression of synthetic function. Levels of total protein, albumin, and coagulation factors (prothrombin index, fibrinogen, proconvertin) decrease.
- Portal hypertension syndrome: due to portosystemic shunting and a decline in detoxification function, blood ammonia levels rise.
- Regeneration and tumor growth syndrome: active proliferation or malignant transformation of cells is accompanied by a surge in alpha-fetoprotein (AFP).
To memorize the main laboratory syndromes, use the mnemonic rule: "Cytolysis — ALT/AST (destruction), Cholestasis — ALP/GGT (bile stasis), Insufficiency — Protein drop (the factory is broken)."
Class and exam questions
What are the risks of sinusoidal capillarization?
It creates a dense mechanical barrier composed of the basement membrane and collagen, hindering metabolic exchange. As a result, hepatocytes receive insufficient oxygen, leading to hypoxia, which only amplifies further damage and fibrosis.
Does fibrosis always disrupt blood flow in the liver?
No, not always. An important feature of the initial stage of fibrogenesis is that the organ's angioarchitectonics and hepatic blood flow are fully preserved.
Which laboratory parameter indicates portal hypertension?
The primary laboratory manifestation is an elevated blood ammonia concentration. This occurs due to the development of portosystemic shunting and a reduction in the liver's toxin-neutralizing function.
What else to study on this topic
- Features of the development of hepatocyte fatty degeneration
- Differential diagnosis of viral and autoimmune injuries
- The role of programmed cell death (apoptosis) in liver pathology
- Mechanisms of portosystemic shunting formation
- Clinical manifestations of hepatic cell insufficiency
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Pathogenesis of Liver Injury and Fibrosis" and 3,738 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in "Chapter 7. Digestive System Diseases"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.